01612 VINCENT MED
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.96X | Oper Margin | 13.9% |
|---|---|---|---|
| LT Debt/Equity | 20.7% | Net Margin | 11.2% |
| Total Debt/Equity | 26.7% | Return on Equity | 15.7% |
| Price/Book | 0.91X | Return on Assets | 8.9% |
| (HKD 0.920) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 104.38 | 69.17 | 57.28 | -17.40 | 60.70 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +50.9 | +20.8 | +429.2 | -128.7 | -72.0 |
| Earnings Per Share (HKD) | 0.162 | 0.108 | 0.089 | -0.027 | 0.093 |
| Earnings Per Share Growth (%) | +50.5 | +21.2 | +433.5 | -128.7 | -72.6 |
| Dividend Per Share (HKD) | 0.050 | 0.033 | 0.028 | 0.025 | 0.045 |
| P/E* (X) | 5.69 | 8.56 | 10.37 | N/A | 9.91 |
| Yield (%) | 5.43 | 3.59 | 2.99 | 2.72 | 4.89 |
| Dividend Share (%) | 30.90 | 30.70 | 31.00 | N/A | 48.49 |
| Book NAV (HKD) | 1.009 | 0.886 | 0.829 | 0.762 | 0.914 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 932.784 | 800.963 | +16.5 | 717.973 |
| Operating Result | 128.797 | 78.307 | +64.5 | 63.645 |
| Associates | 0.844 | -0.328 | -357.3 | 2.817 |
| Profit Before Taxation | 129.641 | 77.979 | +66.3 | 66.915 |
| Taxation | 21.289 | 7.083 | +200.6 | 8.707 |
| Profit /( Loss) After Taxation | 108.352 | 70.896 | +52.8 | 58.208 |
| Minority Interests | 3.974 | 1.729 | +129.8 | 0.933 |
| Net Profit | 104.378 | 69.167 | +50.9 | 57.275 |
| Earnings Per Share () | 0.1618 | 0.1075 | +50.5 | 0.0887 |
| Dividend Per Share () | 0.0500 | 0.0330 | +51.5 | 0.0275 |
| Announcement Date | 2026-03-25 | 2025-03-19 | NA | 2024-03-20 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
